59892-36-3

Usage

Uses

Used in Organic Synthesis:
1-(b-D-Ribofuranosyl)-5-nitropyridine-2-one is used as a synthetic building block for the creation of various organic compounds. Its unique structure allows it to be a valuable intermediate in the synthesis of complex molecules, particularly in the pharmaceutical and chemical industries.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 1-(b-D-Ribofuranosyl)-5-nitropyridine-2-one is used as a key component in the development of new drugs. Its chemical properties make it suitable for the synthesis of therapeutic agents, potentially leading to the discovery of novel medications with improved efficacy and reduced side effects.
Used in Chemical Research:
1-(b-D-Ribofuranosyl)-5-nitropyridine-2-one is also utilized in chemical research to study the properties and reactions of various organic compounds. Its unique structure provides researchers with valuable insights into the behavior of similar molecules, contributing to the advancement of chemical knowledge and the development of new applications in various industries.

Upstream product

• 59892-37-4 1-(2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)-5-nitropyridine-2(1H)-one 
• 14215-97-5 1-O-acetyl-2,3,5-tri-O-benzoyl-D-ribofuranose 
• 656808-98-9 5-nitro-2-trimethylsilanyloxy-pyridine 
• 5418-51-9 5-nitro-2-hydroxypyridine 
• 6974-32-9 1-O-acetyl-2,3,5-tri-O-benzoyl-β-D-ribofuranose 

Downstream Products

• 59892-40-9 4-(β-D-ribofuranosyl)-vic-triazolo[4,5-b]pyridin-5-one 

Relevant academic research and scientific papers

Synthesis of N3,5′-cyclo-4-(β-D-ribofuranosyl)-vic- triazolo[4,5-b]pyridin-5-one and its 3′-deoxysugar analogue as potential anti-hepatitis C virus agents

We recently discovered a novel compound, identified as N 3,5′-cyclo-4-(β-D-ribofuranosyl)-vic-triazolo[4,5-b] pyridinin-5-one, with anti-hepatitis C virus (HCV) activity in vitro. The structure was confirmed by chemical synthesis from 2-hydroxy

Synthesis and structure-activity relationships of novel anti-hepatitis C agents: N3,5′-cyclo-4-(β-D-ribofuranosyl)-vic-triazolo[4, 5-b]pyridin-5-one derivatives

Several 6- and 7-monosubstituted N3,5′-cyclo-4-(β-D- ribofuranosyl)-vic-triazolo[4,5-b]pyridin-5-one derivatives as well as the 5-thiono analogue were synthesized, providing structure - anti-hepatitis C virus (HCV) activity relationships for th

Synthesis of N3,5′-cyclo-4-(β-D-ribofuranosyl)-vic- triazolo[4,5-b]pyridin-5-one, a novel compound with anti-hepatitis C virus activity

A novel anti-hepatitis C virus (HCV) agent, N3,5′-cyclo-4- (β-D-ribofuranosyl)-vic-triazolo(4,5-b]pyridinin-5-one, was identified, and the structure was confirmed by chemical synthesis from 2-hydroxy-5- nitropyridine.